help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2005-0803
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dagogo-Jack, S.
Right arrow Articles by Umamaheswaran, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dagogo-Jack, S.
Right arrow Articles by Umamaheswaran, I.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*HYDROCORTISONE
*METYRAPONE
Medline Plus Health Information
*Obesity
Related Collections
Right arrow Adrenal and Hypertension
Right arrow Metabolism
Right arrow Obesity
The Journal of Clinical Endocrinology & Metabolism Vol. 90, No. 9 5333-5335
Copyright © 2005 by The Endocrine Society


RAPID COMMUNICATION

Inhibition of Cortisol Biosynthesis Decreases Circulating Leptin Levels in Obese Humans

Samuel Dagogo-Jack, Gunjan Tykodi and Indira Umamaheswaran

Department of Medicine and General Clinical Research Center (S.D.-J.), University of Tennessee Health Science Center, Memphis, Tennessee 38163; and Division of Endocrinology, Diabetes and Metabolism (G.T., I.U.), Washington University School of Medicine, St. Louis, Missouri 63110

Address all correspondence and requests for reprints to: Samuel Dagogo-Jack, M.D., University of Tennessee College of Medicine, 956 Court Avenue, Suite D334, Memphis, Tennessee 38163. E-mail: sdj{at}utmem.edu.

Abstract

Context: Glucocorticoids increase both appetite and leptin secretion; the hyperleptinemic effect might be a counterregulatory response to the orexigenic effect of glucocorticoids. However, the effect of glucocorticoid inhibition on leptin production has not been reported.

Objective: We tested the hypothesis that if glucocorticoid-induced hyperleptinemia plays a physiological role, then inhibition of endogenous cortisol biosynthesis should decrease leptin secretion.

Design: A randomized, placebo-controlled, cross-over study design was used.

Setting: The study was carried out at a General Clinical Research Center.

Participants: Eight obese subjects (four men, four women; mean age, 30.4 ± 1.56 yr; mean body mass index, 42.0 ± 1.33 kg/m2) participated in the study.

Intervention: The subjects were treated with metyrapone (750 mg every 4 h) or placebo for 24 h during two overnight admissions, 2 wk apart. Blood sampling for measurement of cortisol, leptin glucose, insulin, and C-peptide was performed hourly for 6 h and every 2 h for 24 h.

Main Outcome Measure: The change in plasma leptin from baseline during metyrapone vs. placebo treatment was measured.

Results: Metyrapone treatment was associated with a significant decrease in plasma cortisol level; the cortisol nadir was 4.84 ± 1.22 µg/dl during placebo and 2.80 ± 0.65 µg/dl during metyrapone treatment (P = 0.009). Compared with placebo, metyrapone treatment was associated with a significant reduction in circulating leptin levels and marked attenuation of the nocturnal rise in plasma leptin (+28.45 ± 11.12% vs. +55.51 ± 5.42%; P = 0.01).

Conclusions: We conclude that metyrapone-induced inhibition of cortisol biosynthesis results in hypoleptinemia, which indicates that glucocorticoids may play an important role in the physiological regulation of leptin.




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
T. M K Volkl, D. Simm, A. Korner, W. Rascher, W. Kiess, J. Kratzsch, and H. G Dorr
Does an altered leptin axis play a role in obesity among children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency?
Eur. J. Endocrinol., February 1, 2009; 160(2): 239 - 247.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. K. Koh, S. M. Park, and M. J. Quon
Leptin and Cardiovascular Disease: Response to Therapeutic Interventions
Circulation, June 24, 2008; 117(25): 3238 - 3249.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Laferrere, C. Abraham, M. Awad, S. Jean-Baptiste, A. B. Hart, P. Garcia-Lorda, P. Kokkoris, and C. D. Russell
Inhibiting Endogenous Cortisol Blunts the Meal-Entrained Rise in Serum Leptin
J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2232 - 2238.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society